£1.2m invested in 9 new research projects for 2019

Published Date
Laura Jacobs

Muscular Dystrophy UK is investing £1.2 million into 9 new research projects this year, bringing our total research portfolio to over £10m.

Some of these projects will investigate methods to improve the delivery of drugs, optimise the use of cough-assist devices and find out how many people are living with muscle-wasting conditions in the UK.

MDUK’s annual grant round sees expert researchers and people living with muscle-wasting conditions select the most relevant, high-quality research to fund. The charity is now funding 56 different projects in the UK and through international partnerships.

Dr Kate Adcock, Director of Research and Innovation at Muscular Dystrophy UK, said:

We are delighted to announce our new projects for 2019. These will increase our knowledge about a number of neuromuscular conditions, help us understand more about delivering treatments and provide an update on the number of people in the UK who are affected by neuromuscular conditions.


Over the past year, research that we have funded has demonstrated structural brain differences in individuals with adult-onset myotonic dystrophy, improved our understanding of the side effects of steroid treatments for Duchenne and showed that a common collagen VI mutation can be corrected using innovative genetic tools.


We look forward to following the progress of our new grants.

This year’s projects

For more information on these grants or any aspect of research into muscle-wasting conditions, contact our Research Line on research@musculardystrophyuk.org and 020 7803 4813.

It is only through your contributions that we can continue to fund the vital work that takes us closer to finding treatments and cures for muscle-wasting conditions. Donate now and help change the lives of thousands of people living with these conditions. Thank you for your support.

Keep in touch